The CooperMEX:COO 89 FCF Margin % is 8.91% as of Apr. 2026, which is 40% below its 10-year median of 14.74. GuruFocus rates MEX:COO with a GF Score™ of 89/100 and a GF Value™ of MXN1,702.46 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, The Cooper ranks better than 81.72% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. The Cooper's Free Cash Flow for the
three
months ended in Apr. 2026 was MXN1,689 Mil. The Cooper's Revenue for the
three
months ended in Apr. 2026 was MXN18,944 Mil. Therefore, The Cooper's FCF Margin % for the quarter that ended in Apr. 2026 was 8.91%.
The historical rank and industry rank for The Cooper's FCF Margin % or its related term are showing as below:
MEX:COO'
s FCF Margin % Range Over the Past 10 Years
Min: 5.98 Med: 14.74 Max: 21.8
Current: 13.51
During the past 13 years, the highest FCF Margin % of The Cooper was 21.80%. The lowest was 5.98%. And the median was 14.74%.
MEX:COO's FCF Margin % is ranked better than 81.72% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs MEX:COO: 13.51
The Cooper FCF Margin % Related Terms
The Cooper FCF Margin % Historical Data
* Premium members only.
The historical data trend for The Cooper's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:COO vs ALGN, SOLV, BAX: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, The Cooper's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's FCF Margin % distribution charts can be found below:
* The bar in red indicates where The Cooper's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (MEX:COO) has a FCF Margin % of 8.91% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on The Cooper and its competitors. This is 40% below median its historical median of 14.74. Over the past decade, The Cooper's FCF Margin % has ranged from 5.98 to 21.80. According to the industry distribution chart, The Cooper ranks #149 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 18.3%.
Is The Cooper's FCF Margin % too high?
The Cooper's current FCF Margin % of 8.91% is 40% below median its 10-year median of 14.74. Over the past 10 years, this metric has ranged from a low of 5.98 to a high of 21.80. Based on the distribution chart, The Cooper ranks #149 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, The Cooper has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's FCF Margin % compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #149 out of 815 companies for FCF Margin %. This places The Cooper in the top 18% of its industry — outperforming the majority of peers. Historically, The Cooper's own FCF Margin % has ranged from 5.98 to 21.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on The Cooper and its competitors. The Cooper's current FCF Margin % is 8.91%, which is 40% below median its own 10-year median of 14.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (MEX:COO) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,702.46, compared to a current price of MXN1,162.20 — trading 31.7% below its estimated fair value. The current FCF Margin % is 8.91%, which is 40% below median its 10-year median of 14.74. The Cooper's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For The Cooper (MEX:COO), the current FCF Margin % is 8.91% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (MEX:COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of MXN1,162.20 is trading 31.7% below its estimated GF Value™ of MXN1,702.46.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for MEX:COO:
FCF Margin %: 8.91% (40% below median its 10-year median of 14.74)
GF Value™: MXN1,702.46 vs. price of MXN1,162.20 (31.7% below fair value)
No single metric tells the full story. See the MEX:COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
89GF Score
Get the complete analysis for MEX:COO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:COO has been successfully added to your 
